mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Randomized comparison of self-fixating and sutured mesh in open inguinal hernia repair

Pierides G et al. – Open inguinal hernia repair with a composite self–fixating mesh resulted in similar pain in the early postoperative convalescence period and at 1 year as repair with a sutured lightweight mesh.

Methods
  • This randomized clinical trial compared inguinal hernia repair using a self–fixating composite mesh or a sutured lightweight mesh, with pain at 1 year as primary outcome.
  • Patients completed a self–evaluation questionnaire at 2 weeks and were examined after 1 year.

Results
  • Some 198 patients received self–fixating mesh and 196 sutured mesh.
  • There were no differences between the groups in mean pain scores measured on a visual analogue scale during 2 weeks of immediate convalescence or at 1 year.
  • Chronic pain and discomfort was experienced by 36•3 per cent of patients in the self–fixating and 34•1 per cent in the sutured mesh group (P = 0•658), affecting the everyday life of 1•1 and 2•8 per cent respectively (P = 0•448).
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close